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Heart development is exquisitely sensitive to the
precise temporal regulation of thousands of genes
that govern developmental decisions during differen-
tiation. However, we currently lack a detailed under-
standing of how chromatin and gene expression
patterns are coordinated during developmental tran-
sitions in the cardiac lineage. Here, we interrogated
the transcriptome and several histone modifications
across the genome during defined stages of cardiac
differentiation. We find distinct chromatin patterns
that are coordinated with stage-specific expression
of functionally related genes, including many human
disease-associated genes. Moreover, we discover
a novel preactivation chromatin pattern at the pro-
moters of genes associated with heart development
and cardiac function. We further identify stage-
specific distal enhancer elements and find enriched
DNA binding motifs within these regions that predict
sets of transcription factors that orchestrate cardiac
differentiation. Together, these findings form a basis
for understanding developmentally regulated chro-
matin transitions during lineage commitment and
the molecular etiology of congenital heart disease.
INTRODUCTION
Developmental decisions during lineage commitment are pre-
cisely coordinated at the genome level as broad gene expres-206 Cell 151, 206–220, September 28, 2012 ª2012 Elsevier Inc.sion programs are jointly activated or repressed (Davidson,
2010).
Heart development requires the concurrent differentiation of
cardiovascular cell types including endothelial cells, smooth
muscle cells, and cardiomyocytes that must be organized into
a complex organ. This process involves specification of pluripo-
tent cells tomesodermal and cardiac precursors prior to terminal
differentiation (Evans et al., 2010; Murry and Keller, 2008; Srivas-
tava, 2006). Thus, heart development depends on precise
temporal control of gene expression patterns, and disruption of
transcriptional networks in heart development underlies con-
genital heart disease (CHD) (Bruneau, 2008; Evans et al., 2010;
Srivastava, 2006). It is not known how groups of genes are cor-
egulated during lineage commitment in the cardiac lineage.
Chromatin regulation is fundamental in specifying different
cell types during embryonic development and in generating
cellular responses to the environment. Studies in mammalian
cells have shown that histone modifications are correlated with
active, repressed, and poised expression states and define cell
state (Barski et al., 2007; Cui et al., 2009; Ernst et al., 2011;
Guenther et al., 2007; Mikkelsen et al., 2007; Zhou et al.,
2011). Histone marks also predict noncoding DNA elements,
such as distal enhancers, that regulate tissue-specific gene
expression (Creyghton et al., 2010; Ernst et al., 2011; Heintzman
et al., 2009; Heintzman et al., 2007; Rada-Iglesias et al., 2011;
Zentner et al., 2011). Although we have considerable knowledge
of the epigenetic landscape of specific cell types, how chromatin
states are coordinated with gene expression during lineage
commitment is poorly understood.
Emerging evidence indicates that faulty epigenetic regulation
contributes to congenital heart disease (Chang and Bruneau,
2012). Mutations in the histone methyltransferase MLL2 in
humans cause congenital heart defects in Kabuki syndrome
(Ng et al., 2010). Transcription factors implicated in inherited
congenital heart disease, such as Tbx5 and Nkx2-5, interact
with histone modifying enzymes to regulate gene expression
(Miller et al., 2008; Miller et al., 2010; Nimura et al., 2009). The
H3K27 methyltransferase Ezh2 regulates gene expression
programs that are important for heart development and homeo-
stasis (Delgado-Olguı´n et al., 2012; He et al., 2012). In addition,
epigenetic changes at cardiac-specific genes are observed
during direct reprogramming of cardiac fibroblasts into cardio-
myocytes (Ieda et al., 2010). Therefore, dissecting the dynamic
chromatin and transcriptional landscapes during cardiomyocyte
differentiation is critical for understanding heart development
and will improve our ability to design stem cell-based therapies
for cardiac-related diseases.
Here, we have defined the dynamic epigenetic and transcrip-
tional landscapes during cardiac differentiation. We used a
directed differentiation system representing the stepwise differ-
entiation of mouse embryonic stem cells (ESCs) into cardiomyo-
cytes (CM) that allows for isolation of developmental intermedi-
ates, including mesoderm (MES) and cardiac precursors (CP).
We analyzed histone modifications at promoters to define chro-
matin states that accompany gene expression changes during
cardiac differentiation. By using a dynamic model of lineage
determination, we discovered previously unknown chromatin
state transitions, including a preactivation pattern associated
with a set of genes with cardiac functions. We also used chro-
matin marks to discover thousands of stage-specific enhancers
that may define new transcriptional networks deployed during
cardiac differentiation. Our data illustrate the strengths of
a differentiation time course in identifying gene regulatory
networks and reveal a chromatin-level determination of cell fates
in the earliest stages of differentiation that may be key to heart
development.
RESULTS
Expression and Chromatin States in Cardiac
Differentiation
We investigated how global patterns of gene expression and
chromatin organization are coordinated in the cardiac lineage.
We used directed differentiation of mouse embryonic stem cells
(ESCs) to cardiomyocytes as amodel system (Figure S1available
online). This approach reproduces normal cardiomyocyte differ-
entiation (Kattman et al., 2011) and resulted in roughly 70%
cardiac Troponin T (cTnT)-positive cardiomyocytes (Figure S1
and Movie S1). Differentiating cultures were highly enriched at
earlier stages for the cardiac transcription factors Nkx2-5 and
Isl1, indicating that these cells progress efficiently through nor-
mal cardiac differentiation (Figure S1). Based on marker gene
analysis, we selected four stages of differentiation that represent
keycell types in the transition frompluripotent cells to cardiomyo-
cytes (Figure 1A): undifferentiated embryonic stem cells (ESC)
expressing pluripotency genes (Pou5f1/Oct4 and Nanog), cells
expressing mesodermal markers (Mesp1 and Brachyury) (MES),
cells expressing cardiac transcription factors (Nkx2-5, Tbx5,
and Isl1) but not yet beating (CP), and functional CM with cardio-
myocyte-specific gene expression (Myh6 andMyh7).We analyzed global expression patterns of polyadenylated
transcripts and microRNAs (miRNAs) in the four cell types by
RNA sequencing (RNA-Seq) and Nanostring, respectively. We
identified over 13,500 genes expressed during the time course
(reads per kilobase per million [RPKM] > 1). Genes were clus-
tered by expression pattern using HOPACH (Pollard et al.,
2005), yielding distinct clusters (Figure 1B, Figure S2, Table
S1), including groups of genes specifically expressed at each
stage (e.g., Clusters A, L, N, and S). The stage-specific clusters
were enriched for expected Gene Ontology (GO) terms (Table
S2). Using the Nanostring platform, we analyzed over 600
miRNAs and found that they also display dynamic and stage-
specific expression (Figure 1C, Table S1). Our data confirmed
expression of key ESC miRNAs, such as the miR290 cluster,
as well as known cardiac miRNAs (including miR-1, miR-208,
and miR-143) in the CM stage. These data also identify several
other stage-specific miRNAs that represent potential new regu-
lators of cardiac differentiation.
Long ncRNAs (lncRNAs) are noncoding polyadenylated tran-
scripts with emerging roles in gene regulation (Pauli et al.,
2011). LncRNAs are differentially expressed in mammalian cell
types, suggesting roles in lineage commitment (Cabili et al.,
2011). However, lncRNAs have not yet been implicated in heart
development. Notably, we find that lncRNAs show striking
stage-specific expression in our differentiation system (Fig-
ure 1D, Table S1). LncRNAs regulate gene expression in cis
and trans and may also function as transcriptional enhancers
(Ørom et al., 2010). We expected that if lncRNAs function in cis
to regulate lineage commitment, then their neighboring genes
should have functions related to this process. To test this idea,
we determined GO enrichment for the two nearest genes relative
to lncRNAs expressed >1 RPKM in at least one stage (Figures 1D
and 1E). Consistent with our hypothesis, we found enrichment of
genes involved in development, morphogenesis, and transcrip-
tional processes (Figure 1F).
We find that lncRNAs identified in our data are significantly
correlated in expression with their neighboring genes compared
to randomly selected neighboring protein coding genes (hyper-
geometric test p = 4 3 1032). We tested the possibility that
the observed correlations are attributable to coordinately regu-
lated gene clusters, however, we find that lncRNA expression
is more highly correlated with the nearest adjacent gene
(p = 0.0275) relative to our background model (Figure 1F,
Extended Experimental Procedures). Our data suggest that
some lncRNAsmay regulate gene expression in cis during cardi-
omyocyte differentiation. Moreover, we find many correlated
lncRNA-gene pairs are associated with known cardiac genes
such as Gata6, Hand2 and Myocd (Figure 1G, Table S1). These
data identify several potential noncoding regulators andwill facil-
itate further study of lncRNAs in cardiogenesis.
Chromatin State Dynamics during Cardiac
Differentiation
Chromatin structure is key to transcriptional regulation, yet its
role during differentiation is largely unknown. To this end, we per-
formed chromatin immunoprecipitation and massively parallel
sequencing (ChIP-Seq) for several histone modifications at the
time points examined for gene expression (ESC, MES, CP, andCell 151, 206–220, September 28, 2012 ª2012 Elsevier Inc. 207
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Figure 2. Chromatin State Transitions during Cardiac Differentiation
(A) Hierarchal clustering of genes based on enrichment of histone modifications and RNA Polymerase (serine 5 phosphorylated) within 2 kb of the TSS. Color
represents median enrichment for each cluster of genes. Number of genes within each cluster is shown on the right.
(B) The overlap of genes between chromatin clusters (vertical axis) and expression clusters (horizontal axis). Color represents the Pearson residuals. Yellow
represents significant overlap between the genes within chromatin cluster and expression cluster. See also Table S3.CM). Modifications included H3K27me3 and H3K4me3 (associ-
ated with inactive and active promoters respectively) and
H3K4me1 and H3K27ac (associated with promoters and
enhancers) (Barski et al., 2007; Cui et al., 2009; Ernst et al.,
2011; Mikkelsen et al., 2007; Zhou et al., 2011). We also deter-
mined binding of RNA polymerase II phosphorylated at serine
5 (RNAP), which is enriched at transcriptional start sites (TSS).
Given the dynamic nature of gene expression observed during
cardiomyocyte differentiation, we initially focused on elucidating
histone modification patterns at transcription start sites (TSSs).
To identify gene promoters with similar patterns, we performed
unsupervised clustering of ChIP signal 2 kb around the TSS
of each gene (Figure 2A, Table S1, and Extended Experimental
Procedures). Consistent with previous studies showing littleFigure 1. Transcriptional Analysis of Cardiac Differentiation
(A) The four stages of differentiation analyzed in this study.
(B) Hierarchical clustering of coding and non-coding polyA+ gene expression, acr
right.
(C) Hierarchical clustering of miRNA expression (565 miRNAs included in NanoS
(D) Hierarchical clustering of lncRNA expression including 196 lncRNAs express
(E) Enriched GO terms for the two nearest genes adjacent to the lncRNA genes
(F) Expression correlation between lncRNAs and adjacent geneminus correlation
as compared to background model generated by randomly sampling similar sets
plotted as the black curve. Difference in expression correlation for lncRNAs is si
(G) Example lncRNAs and highly correlated adjacent genes identified in expressio
heart development (Gata6, Hand2 and Myocd) and expression pattern during thevariation of chromatin patterns at promoters across cell types
(Heintzman et al., 2009), the largest cluster, Cluster 1, had high
levels of H3K4me3, H3K27ac, and RNAP (all associated with
active chromatin and transcription) across the time course. GO
analysis showed that these genes are involved in fundamental
cellular functions, such as metabolism and cell-cycle regulation
(Table S3). Other clusters, however, revealed dynamic chromatin
patterns, suggesting chromatin regulation is critical to cardiac
gene expression and differentiation.
Dynamic Chromatin States Correlate with Distinct
Expression Patterns
We considered that genes with similar temporal expression
patterns would share a common chromatin pattern. Conversely,oss the four cell types. Enriched GO terms and example genes are shown to the
tring probe set).
ed at >1 RPKM in at least one time point.
expressed in the time course.
of adjacent gene with the other neighbor in a three gene set in a 100 kb window,
of three genes. Distribution of the correlation differences in the background is
gnificant (p = 0.0275, red line) relative to our background model.
n clusters N, Q, and S. Graphs display examples of genes with known roles in
time course. See also Tables S1 and S2, Figures S1 and S2, and Movie S1.
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common expression patterns may be represented by multiple
different chromatin patterns. To test this, we tabulated the
number of genes shared between each chromatin and expres-
sion cluster and determined statistical enrichment (Figure 2B).
We found that the mesoderm-specific expression cluster L
is primarily associated with chromatin cluster 9. However, the
ESC-specific expression cluster A, comprising genes rapidly
silenced upon differentiation, correlated with several chromatin
patterns, including chromatin cluster 5, where active marks are
lost without gain of additional marks tested, and cluster 11,
where active marks are gradually lost while gaining the repres-
sive H3K27me3 modification (Figure 2A). Regulators of stem
cell state fell into more than one cocluster (A11 Pou5f1/Oct4,
and A5 Nanog), suggesting expression of pluripotency regula-
tors is controlled by multiple epigenetic mechanisms.
We next examined how chromatin and expression patterns
were coordinated at each stage of differentiation. We find that
genes with similar expression patterns showed considerable
variation in chromatin states during differentiation. For instance,
genes in cocluster A11 include active genes with highly corre-
lated chromatin states at the ESC stage (Figure 3). Upon differ-
entiation, these genes were downregulated at the MES stage.
However, this initial change in expression did not correlate with
changes in chromatin until later in differentiation at the CP stage.
Conversely, genes in the mesoderm-specific expression Cluster
L9 (Figure 3B), which are expressed at the MES stage and
repressed at the CP stage, correspondingly have highly corre-
lated active MES and silent CP chromatin states.
Our analysis also revealed that chromatin patterns could
distinguish functionally distinct genes with a similar expression
pattern (Figure 3C). For example, expression cluster S com-
prises genes expressed at the CM stage that are associated
with diverse chromatin patterns, such as H3K4me3 and no
H3K27me3 (S3), H3K4me3 and H3K27me3 (S8 and S10), and
gain of low levels of H3K4me3 during differentiation without
H3K27me3 enrichment (S20, S23, S24, S26, S27, and S28).
However, each subgroup includes genes involved in distinct
processes, including metabolism (S3), signaling (S8 and S10),
and muscle contraction (S20, S23, S24, S26, S27, and S28).
This indicates that despite similar expression patterns, groups
of functionally related genes can be distinguished at the
chromatin level.
A Novel Chromatin State Transition during CM
Differentiation
Our promoter clustering revealed a group of genes that showed
enrichment for H3K4me1 enrichment prior to enrichment of
H3K4me3 and RNA Pol II and transcriptional activation. As
H3K4me1 has largely been associated with open chromatin at
distal enhancers prior to activation (Creyghton et al., 2010; Ernst
et al., 2011; Heintzman et al., 2009; Rada-Iglesias et al., 2011;
Zentner et al., 2011), we hypothesized that H3K4me1 may
mark a similar promoter state. Although we found H3K4me3
and H3K4me1 were often enriched at the same TSSs, a fraction
(15%–20%) of genes marked by H3K4me1 was not H3K4me3
enriched (Figure 4A) and was poorly expressed (Figure 4B).
These included many contractile protein genes, such as Actc1,
for which H3K4me1 was present at the MES stage prior to210 Cell 151, 206–220, September 28, 2012 ª2012 Elsevier Inc.transcriptional activation at the CP and CM stages (Figure 4C).
Notably, H3K27me3 was not enriched at these promoters, sug-
gesting that this group of genes was not repressed by Polycomb
during cardiomyocyte differentiation.
To gain broader insights, we classified genes based on the
pattern of H3K4me1 and H3K4me3 at their TSS. We identified
three gene groups that showed interesting patterns of these
modifications (Figures 4D and 4E). Group 1 gained H3K4me1
prior to H3K4me3 enrichment and transcriptional activation
and was enriched exclusively for cardiovascular genes including
those encoding contractile proteins associated with terminal
differentiation and cardiomyocyte function. H3K4me1 was often
maintained at these TSSs upon H3K4me3 enrichment and gene
activation. Group II gained H3K4me1 over time but failed to gain
H3K4me3 or robust expression and included muscle lineage
genes such as Ckm, Ckmt2, and Tcap, whose expression is
associated with cardiomyocyte maturation. Group III genes
transiently gained H3K4me1 at specific stages, but showed no
H3K4me3 enrichment during differentiation. These genes were
not expressed above background levels throughout differentia-
tion and function in noncardiac lineages. Group II and III genes
did not acquire H3K27me3 suggesting Polycomb-independent
silencing. Although the functional role of the H3K4me1 preacti-
vation pattern is unknown, chromatin remodelling at early stages
of cardiac differentiation may be necessary for gene activation
during terminal differentiation.
Enhancer Activity Correlates with Cardiac Specific
Programs
Although regulation at promoters is important for gene regula-
tion, distal enhancers are key regulators of tissue-specific gene
expression patterns during lineage commitment. In addition to
their enrichment at TSSs, H3K4me1 and H3K27ac demarcate
enhancer elements in a wide range of cell types (Creyghton
et al., 2010; Ernst et al., 2011; Rada-Iglesias et al., 2011; Zentner
et al., 2011). Using these modifications, we identified 81,497
putative distal enhancer regions during cardiac differentiation
(Figures 5A and 5B, Figures S3A–S3C, Table S4, and Extended
Experimental Procedures). H3K4me1 marks most elements at
each stage, whereas H3K27ac is enriched at a subset of these
regions (Figure 5A). The broad enrichment of H3K4me1 is con-
sistent with the idea that it represents a general mark of en-
hancers and open chromatin (Creyghton et al., 2010; Ernst
et al., 2011; Heintzman et al., 2009; Rada-Iglesias et al., 2011;
Zentner et al., 2011). Comparing our data to H3K4me1 and
H3K27ac profiles from neural precursors, liver, and pro B cells
(Creyghton et al., 2010) revealed that our enhancers are largely
unique to the cardiac lineage (Figure S3D).
Our predicted set of enhancers significantly overlaps the
smaller sets identified by p300/CBP binding in fetal mouse heart,
fetal or adult human hearts, or by the binding of multiple tran-
scription factors in the HL1 cardiomyocyte cell line (Blow et al.,
2010; He et al., 2011; May et al., 2012), which supports our
enhancer predictions (Figures S3D and S3E). Consistent with
evidence indicating that cardiac enhancers are conserved over
a limited phylogenetic distance (Blow et al., 2010; May et al.,
2012), we find our predicted enhancers have low overlap with
highly conserved (>600) Phastcons elements, which increases
Figure 3. Dynamic and Highly Correlated Chromatin and Gene Expression Patterns during Cardiomyocyte Differentiation
(A) Heat maps (top) of magnitude transformed, chromatin fold enrichment values and gene expression values, for cocluster A11. Cocluster A11 correlation
network (bottom), where nodes represent genes in each module and edges (red lines) represent Pearson correlations of chromatin marks, calculated with the
magnitude transformed values. Node color corresponds to gene expression state; yellow and black indicates up- and downregulated expression, respectively.
(B) Cocluster L9, analyzed as in (A).
(C) Subgroups of expression cluster S based on chromatin pattern segregate genes with distinct gene ontology. Chromatin and gene expression values are
represented as median ± interquartile range among all genes graphed. Expression values were normalized by interquartile range within each gene.significantly when considering only highly conserved elements in
placental mammals (Figures S3F and S3G). Thus, our analysis
identified many putative heart enhancers that likely function in
heart development, including novel enhancers that may regulate
the transition from pluripotency to a functionally differentiated
state.
Histone modification patterns can distinguish active en-
hancers (which correlate with tissue-specific expression) from
poised enhancers (which correlate with potential gene expres-sion later in development) (Creyghton et al., 2010; Ernst et al.,
2011; Rada-Iglesias et al., 2011; Zentner et al., 2011). We classi-
fied our enhancers as active (H3K27ac+, H3K4me1+/) or
poised (H3K4me1+ only) at each stage of differentiation (Fig-
ure 5C). We find most enhancers at a given stage are poised,
whereas a smaller subset is active. We then compared enrich-
ment patterns of several other histone modifications and RNAP
with these enhancer regions. We find that RNAP is highly en-
riched at active enhancers (Figure 5C), consistent withCell 151, 206–220, September 28, 2012 ª2012 Elsevier Inc. 211
Figure 4. H3K4me1 Marks Cardiac Contractile Genes prior to Gene Activation
(A) Fraction of H3K4me1-marked genes that overlap with H3K4me3. An enrichment value at the TSS of 3 was used as the threshold to distinguish marked from
unmarked genes.
(B) Average expression (RPKM) of genes marked with H3K4me1, H3K4me3, both H3K4me1 and H3K4me3, or neither modification for each stage of differen-
tiation.
(C) Example of a preactivated gene,Actc1. ChIP-Seq (H3K4me1, H3K27ac, H3K4me3, y axis reads/million uniquemapped reads), andRNA-Seq (FPKM) genome
tracks (mm9) are shown. Scale for each modification is constant throughout the time course.
(D) Classification of genes based on gain of H3K4me1 and H3K4me3 enrichment at the TSS. Enrichment for genes with MGI cardiovascular expression was
calculated using a Pearson residual.
(E) Example genes for each group. Left axis represents mean normalized chromatin enrichment values at the TSS. Right axis represents RPKM expression
value.
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Figure 5. Identification of Enhancer Elements during Cardiac Differentiation
(A) Total distal enhancers identified in ESC, MES, CP, and CM categorized by H3K27ac and H3K4me1 status at each stage.
(B) Distribution of enhancers across the genome.
(C) Density of ChIP-Seq reads ±4 kb relative to the midpoint of enriched regions for H3K4me1, H3K27ac, and RNA Polymerase (serine 5 phosphorylated form).
(D) Boxplots of log2 transformed (FPKM) gene expression values for single nearest gene associated with unmarked (U), poised (P), and active (A) enhancer
groups. p values determined by Wilcoxon rank sum test with continuity correction. Boxplots show interquartile ranges (IQR) with whiskers extending to the
furthest data point that was no further than 1.5 times the IQR from the interquartile boundaries.
(E) Log(Binomial FDR Q value) scores for GO Biological Process enriched in single nearest gene associated with active enhancers.transcription initiation at these regulatory elements (Kim et al.,
2010). Conversely, although H3K27me3 has been shown to
demarcate poised enhancers elements (Rada-Iglesias et al.,
2011; Zentner et al., 2011), this mark had a minimal overlap
with our enhancer regions (Figure S4). Thus, while poised and
active enhancers can be broadly defined by a limited set of
histone modifications, there likely exist many other substates
that comprise functionally distinct enhancer states.
To test whether active enhancers correlate with stage specific
gene expression, we assigned active enhancers to their singlenearest gene (Table S4) and found that genes associated with
active enhancers are expressed at significantly higher levels
than genes associated with unmarked or poised enhancers at
each stage (Figure 5D). GO analysis of genes associated with
active enhancers revealed enriched categories that progres-
sively become cardiomyocyte-specific (Figure 5E, Figure S5A,
Table S5). For example, enhancer-associated genes at the
MES stage function in mesoderm and embryonic pattern speci-
fication, whereas at the CP stage they function in heart morpho-
genesis and cardiac tissue development. In CMs, we observeCell 151, 206–220, September 28, 2012 ª2012 Elsevier Inc. 213
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a transition to genes involved in cardiomyocyte structure and
function. Many of these genes have important roles in heart
development and their dysregulation is associated with heart
defects and cardiovascular disease (Bruneau, 2008; Srivastava,
2006). Thus, we identified many new putative enhancers that
correlate with genes involved in cardiac specification during
embryonic development.
Enhancer Transitions during CM Differentiation
To dissect enhancer state transitions that govern cardiac
gene expression programs, we clustered enhancers according
to their states (unmarked, poised, or active) at each stage
(Figure 6A). The set of active and poised enhancers is largely
unique at each stage, indicating that enhancers are highly
cell type-specific even between closely related cell types.
A subset of enhancers showed poised-to-active state transi-
tions concomitant with activation of the proximal gene (e.g.,
Myh7 and Nkx2-5) (Figure 6B, Figure S6). However, most
poised enhancers failed to acquire an active state during cardi-
omyocyte differentiation. These initially poised enhancers may
be required to specify cell fates in other lineages during early
development, suggesting that cells retain significant plasticity
during lineage commitment.
The dynamic cell-type specificity of enhancer usage sug-
gested that transitions between poised and active enhancer
states occur rapidly between stages. Consistent with this,
comparing enhancer states between each stage of cardiac
differentiation showed that the fraction of active enhancers
that transition through a poised state is largest during the MES
to CP and CP to CM transition and lowest between unrelated
cell types (Figure 6C and Figure S5). Although enhancer transi-
tions between ESCs and the differentiated cell types remain
below 5%, they comprise 22% to 56% during the MES-CP
transition, respectively (Figure S5). The cell type specificity and
rapid state transitions of enhancers suggests dynamic enhancer
usage is an important regulatory mechanism for coordinating
tissue-specific gene expression.
Integrating Enhancers into Gene Networks
Although enhancers regulate global developmental gene
expression patterns, integrating these genomic elements into
the core transcriptional regulatory circuitry is challenging. Tran-
scription factors (TFs) can act as master regulators of gene
expression programs by binding to specific motifs within cis-
regulatory elements. Given the stage-specific expression of
TFs in our time course (Figure 7A, Figure S2), we hypothesized
that motifs for TFs that drive cardiac development would be en-
riched in active enhancers. Reasoning that TFs bind open chro-
matin regions (He et al., 2010; Verzi et al., 2010), we developed
an algorithm to find depressions in the H3K27ac chromatin
profile at active enhancer regions and used these regions toFigure 6. Transitioning Enhancer States during Cardiac Differentiation
(A) Union set of enhancers combined from all 4 time points during cardiomyocyt
(H3K27ac+;H3K4me1+/) enhancers.
(B) Example ChIP-Seq (H3K4me1, H3K27ac, H3K4me3, y axis reads/million uniqu
modification is constant throughout the time course.
(C) Enhancer state transitions in similar cell types relative to distant cell types.search for motifs. We found over-represented motifs at each
stage, including those for TFs that regulate the ESC state
(OCT4_01, LRH1_Q5, and 500seq_marson) and cardiac devel-
opment (GATA_Q6, MEF_Q6_01, MEIS1BHOXA9_02, and
SRF_C) (Figure 7B). We compiled a list of TFs known to bind
these highly conserved motifs and found strong correlations
between TF expression and motif enrichment at each stage (Fig-
ure 7C). To address whether these predictions represented
binding events, we analyzed ChIP-Seq data for OCT4 and
SOX2 in ESCs (Marson et al., 2008) and GATA4 in the HL-1 car-
diomyocyte cell line (He et al., 2011). OCT4 and SOX2 bound
regions substantially overlapped the OCT4_01 and SOX9_B1
motifs at enhancers in ESCs (p = 2 3 1074 and 3 3 1026) (Fig-
ure S5D). GATA4 bound regions strongly correlated with en-
hancers that have a GATA_Q6 motif (p = 3 3 1074 and 2 3
1030 respectively) at the CP and CM stage.
To construct gene regulatory networks connected to specific
TF-motif pairs, we selected target genes positively correlated
with TF expression. We find that many of these pairs were asso-
ciated with genes that function in common pathways. For
example, at the CP stage, MEIS, GATA, and NFATC enhancer-
associated genes comprise networks implicated in cardiovas-
cular development and function (Figure 7D, Figure S7). Although
Meis1 and Meis2 have been implicated in heart development
(Crowley et al., 2010; Pfeufer et al., 2010; Stankunas et al.,
2008), their targets in cardiac differentiation are unknown. Our
data suggest MEIS1/2 regulate a subset of genes important
in cardiac morphogenesis. Moreover, GATA factors potentially
bind enhancers that may regulate important cardiac genes,
including Nkx2-5, Mef2c, and Gata4 itself (Bruneau, 2008; Sri-
vastava, 2006).
We further tested our enhancer predictions by analyzing the
effects of loss of function of particular TFs on gene expression.
Genes in the predicted OCT4-regulated network were highly
correlated with genes affected by Oct4 knockdown (p = 3 3
1044) (Loh et al., 2006). Despite considerable redundancy
among GATA factors (Zhou et al., 2012), we found the GATA4
network also predicted many genes differentially regulated in
Gata4 knockdown HL-1 cells (He et al., 2011) (p = 9 3 1012 at
CP stage, p = 9 3 1015 at CM stage). These data indicate
that we have identified a set of TFs that may regulate specialized
gene expression networks by binding to distinct sets of en-
hancers during cardiomyocyte differentiation.
Combinatorial interactions among transcription factors can
increase the diversity of regulatory modules governed by a par-
ticular factor. We observed a significant overlap among target
genes associated with enhancers containingMEIS1BHOXA9_02
andGATA_Q6motifs at the CP stage (Figure 7E, Table S6). Upon
further analysis, we identified groups of developmentally impor-
tant genes regulated by only GATA, only MEIS, or MEIS and
GATA together suggesting independent as well as coregulatione differentiation clustered based on Unmarked, Poised (H3K4me1+) or Active
e mapped reads) and RNA-Seq (RPKM) genome tracks (mm9). Scale for each
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byMEIS/HOX and GATA factors. Enhancers coenriched for both
MEIS and GATA motifs are associated with genes important for
cardiac development, such asGata5, Irx4,Myocd, Zfpm2,Wnt2,
and Smarcd3, and with genes that influence conduction system
function (Hcn4), consistent with an association of MEIS1 with
conduction parameters (Pfeufer et al., 2010). Notably, we find
MEIS/GATAmotifs are often enriched in the same enhancer (Fig-
ure 7F), suggesting a functional relationship between these
factors.
We used luciferase reporter activation assays to test for core-
gulation by MEIS and GATA factors. We tested five enhancers
with motifs for MEIS and GATA, including a Myocd enhancer
active in the developing heart (Creemers et al., 2006). Cotrans-
fection of the Myocd reporters with combinations of expression
constructs for GATA4, MEIS1A, or MEIS2D, showed that this
enhancer responded toGATA4 andwas synergistically activated
by the combination of GATA4 and MEIS1A (Figure 7G). This
appeared to be specific to MEIS1A, because cotransfection of
MEIS2D with GATA4 did not lead synergistic activation. Further-
more, most (four of five) enhancers tested were synergistically
activated by the combination of MEIS1A and GATA4 (Fig-
ure S7C). Thus GATA4 and MEIS1A can function together to
activate certain cardiac enhancers.
Collectively, our work reveals a detailed picture of how gene
expression programs may be coordinated during lineage com-
mitment and provides novel insights into the key principles that
underpin heart development and disease.
DISCUSSION
We have defined chromatin state transitions during cardiac
differentiation that provide insights into the dynamic regulation
of cellular differentiation and the coordinated regulation of
gene expression programs. Our results show that there are
complex but distinct chromatin patterns that accompany lineage
decisions.
Dynamic Epigenetic Transitions in Differentiation
The rapid loss of expression of pluripotency-associated genes
upon differentiation can be achieved by at least nine different
chromatin patterns. These patterns comprise broad groups
that include loss of active marks (e.g., Nanog), or gradual loss
of active marks with the simultaneous acquisition of repressive
marks (e.g., Oct4/Pou5f1). Conversely, during cardiac differenti-
ation, we observed striking coherence among most mesoderm-Figure 7. Enhancer Gene Networks Critical for Heart Development
(A) Hierarchical clustering of magnitude normalized FPKM values for transcripti
(TF1–TF7).
(B) Clustering of magnitude normalized density based motif enrichment scores (
(C) Pearson correlation matrix between enriched TF motifs and the expression p
(D) Examples of predicted target gene networks. Grey nodes represent genes id
(E) Venn diagram shows overlap betweenMEISHOXA9 andGATA6_Q6motif cont
(F) Graphical representation of the preference for MEISHOXA9 and GATA6_Q6mo
targets.
(G) Meis1a and Gata4 synergistically activate theMyocd enhancer. A graphical re
shown. The graph shows relative luciferase reporter activity normalized to repor
Data are represented as mean + SEM. n = 4; ***p < 0.001 by ANOVA.specific genes, which share a specific chromatin pattern. On the
other hand, genes expressed in later development can be clas-
sified by multiple distinct chromatin regulatory patterns that
may precisely coordinate precursor and differentiated cardio-
myocyte gene expression programs.
Our data also reveal that chromatin patterns can predict sets
of functionally related genes. For example, genes associated
with metabolic function share a similar chromatin pattern,
whereas those involved in contractile function and sarcomere
structure have a distinct pattern, although they share a similar
expression profile. This implies that functionally related and
coexpressed genes have specific modes of regulation. Distinct
modes of epigenetic regulation may exist to ensure that
functional gene modules are synchronized, thus ensuring
robust and coordinated expression of key processes that may
be critical for cell function and importantly for adaptation to
stress.
A Novel Dynamic Pattern of Histone Modifications
Analysis of chromatin states during cardiomyocyte differentia-
tion has led to the identification of novel patterns that are highly
informative to understand developmental regulatory programs.
In particular, we have identified a pattern of H3K4me1 deposition
at the TSS that precedes the transcriptional activation and
acquisition of H3K4me3 and recruitment of RNAP. This preacti-
vation pattern is consistent with the idea that molecular events in
early lineage commitmentmark genes for subsequent activation.
A similar pattern has been observed in T cell differentiation, in
which H3K4me2 precedes transcriptional activation for a select
group of genes (Zhang et al., 2012). This preactivation pattern is
likely important for genes that are not regulated by Polycomb
complexes. The presence of H3K4me1 in anticipation of tran-
scriptional activation is reminiscent of its presence at poised
enhancers, for which only a minority show H3K27me3 enrich-
ment. It is possible that H3K4me1maymark regulatory elements
such as proximal enhancers that may function to poise the TSS
for activation. These data suggest that diverse mechanisms can
poise specific classes of TSSs and enhancers for subsequent
activation. We propose that early deposition of H3K4me1 at
specific cardiac genes is a regulated step that facilitates later
activation of these genes. It will be important to identify the chro-
matin regulator that is necessary to catalyze this modification as
well as the factors required for its recruitment and whether the
early deposition of this mark is required for proper activation of
these genes.on factors expressed during cardiac differentiation, subdivided into 7 groups
log(p value)) shows stage specific enrichment of highly conserved TF motifs.
attern of TFs known to bind the list of highly conserved motifs.
entified via motif enrichment analysis.
aining target genes, with associated GO terms for unique and common targets.
tifs to occupy the same enhancer versus separate enhancers at common gene
presentation of the candidate MEIS and GATA sites within the enhancer dip are
ter construct alone.
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Identification of Transcriptional Networks Based on
Enhancer Predictions
Chromatin marks at genomic regions distal to the TSS provides
a means to identify candidate enhancer elements (Creyghton
et al., 2010; Rada-Iglesias et al., 2011). We have identified a large
number of enhancers that show stage-specific activation. This
richdata set hasallowedus todiscover transcription factormotifs
that predict novel enhancer-driven transcriptional regulatory
networks during cardiomyocyte differentiation. For example, we
identified networks for the GATA family of transcription factors
that include GATA4, GATA5, and GATA6 in CP and CM stages.
TheGATA factors are known to orchestratemany developmental
processes. In the developing heart, these transcription factors
have broad roles in early differentiation, morphogenesis, and
postnatal physiology (Zhao et al., 2008; Zhou et al., 2012). Muta-
tions inGATA4 lead tocongenital heart defects (Garget al., 2003),
highlighting the importance of elucidating how these factors
regulate gene expression programs in heart development.
We also discovered potential new regulators of cardiac
development. We identified enrichment for the MEIS1BHOXA9
motif, which predicts the binding of Meis factors, perhaps
along with a partner Hox factor, at a subset of enhancers at
the CP stage. Meis1 has been implicated in heart development
becauseMeis1 null mice display congenital heart defects (Stan-
kunas et al., 2008) and because MEIS1 has been identified in
genome-wide association studies (GWAS) of human arrhythmias
(Pfeufer et al., 2010). Chromosomal deletions that includeMEIS2
have also been identified in patients with congenital heart
defects (Crowley et al., 2010). Our expression data show that
both Meis1 and Meis2 are robustly and transiently activated at
the CP stage, consistent with a role in cardiac progenitors.
Thus, we have identified a novel network potentially under
control of Meis factors. Finally, we observed a striking overlap
between GATA- and the MEIS1BHOXA9-binding sites at en-
hancers, and show that these enhancers can respond to
GATA4 and Meis1 in reporter assays. Thus we have uncovered
a previously unknown functional relationship between GATA
and Meis TFs in heart development.
Together, our study establishes a platform to understand
the process of cardiomyocyte differentiation and provides an
opportunity to identify mechanisms of complex disease loci by
comparison with GWAS. Moreover, our data lay the foundation
for understanding how the epigenetic landscape of cardiac
differentiation integrates transcriptional inputs during normal
development. These insights will be valuable to develop im-
proved cardiac reprogramming strategies (Ieda et al., 2010;
Qian et al., 2012; Song et al., 2012; Takeuchi and Bruneau,
2009) and to elucidate how disruption of these diverse regulatory
modules contributes to congenital heart disease.
EXPERIMENTAL PROCEDURES
Detailed experimental and analysis methods can be found in the Extended
Experimental Procedures.
Cardiomyocyte Differentiation and Analysis
E14 Tg(Nkx2-5-EmGFP) mouse ES cells (Hsiao et al., 2008) were cultured in
feeder-free conditions using standard techniques. Directed differentiations
and analyseswere performed essentially as described in (Kattman et al., 2011).218 Cell 151, 206–220, September 28, 2012 ª2012 Elsevier Inc.RNA-Seq and Analysis Pipeline
Total RNA was isolated from 5 3 106 cells using TRIzol Reagent. Sequencing
libraries were prepared according to Illumina RNA-Seq library kit with minor
modifications. Paired-end RNA-Seq 36 base pair reads were aligned to
mm9 (Mus musculus assembly July 2007). DESeq (Anders and Huber, 2010)
was used to normalize raw read counts and analyze differential gene expres-
sion. USeq 7.0 (Nix et al., 2008) was then used to generate gene-level read
counts and estimate RPKM (reads per kilobase of exon per million reads map-
ped). Only geneswith expression values >1RPKM in at least one cell typewere
considered for subsequent analysis. Expression was normalized to the inter-
quartile range across the time course; interquartile numbers were used for
clustering using a cosine angle distance metric and the Hopach cluster-
ing package (http://www.bioconductor.org/packages/2.1/bioc/html/hopach.
html).ChIP-Seq and Analysis Pipeline
Genome-wide localization of histone modifications (H3K4me3, H3K4me1,
H3K27me3, and H3K27ac) and the serine 5 phosphorylated form of RNA Pol
II for each stage was determined via chromatin immunoprecipitation followed
by high throughput sequencing. Chromatin immunoprecipitations were per-
formed according to the Young lab protocol (Lee et al., 2006) with minor modi-
fication. Details on analysis pipeline can be found in Extended Experimental
Procedures.Transient Transactivation Assays for Enhancer Validation
Candidate enhancers were cloned into a modified pGL3 luciferase reporter
construct. Expression constructs for Gata4, Meis1a, and Meis2d (250 ng
each) were cotransfected with each reporter construct (500 ng each) in
10T1/2 cells. Luciferase activity was assessed 40 hr later and normalized to
Renilla luciferase activity. Conditions were analyzed for statistical differences
using a one-way repeated-measures ANOVA followed by Tukey’s Multiple
Comparison Test.ACCESSION NUMBERS
All sequencing reported in this article have been deposited in the GNomEx
database under accession numbers 44R and 7R2 and can be found at
https://b2b.hci.utah.edu/gnomex/ by using the guest login.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, six tables, and one movie and can be found with this article online at
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